US-Based NeoImmuneTech Targets 96 Billion Won IPO in KOSDAQ
U.S.-based immunotherapy NeoImmuneTech (NIT) announced last Monday that it plans to raise around 96 billion won ($86.9 million) from its ...
Tag: 96 billion won
U.S.-based immunotherapy NeoImmuneTech (NIT) announced last Monday that it plans to raise around 96 billion won ($86.9 million) from its ...